Advertisement

The use of drugs in the control of the problem behaviour of people with profound retardation and multiple impairments

  • C. Kiernan

Abstract

Any substance which we eat, breathe, have applied to the skin or have injected, can affect behaviour. Some substances have indirect effects: perfumes, or the smell of cooking food, may make us feel happy. Cigarette smoke may induce serious illness and lead to death. Food in general is necessary to sustain health but some people are allergic to certain types of food, for example dairy products, or to certain types of food additives, and may become irritable or overactive. Antibiotics, taken for common complaints, may make people feel drowsy or depressed. In this chapter we will consider the effects of one group of substances, psychoactive drugs, on problem behaviour in people with profound retardation and multiple impairments.

Keywords

Problem Behaviour Sleep Problem Temporal Lobe Epilepsy Tourette Syndrome Psychoactive Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Al-Kaisi, A.H. and McGuire, R.J. (1974) The effect of sulthiame on disturbed behaviour in mentally subnormal patients. Br. J. Psychiatry, 124, 45–9.PubMedCrossRefGoogle Scholar
  2. Aman, M.G. and Singh, N.N. (1983) Pharmacological intervention, in Handbook of Mental Retardation (eds J.L. Matson and J.A. Mulick ), Pergamon Press, New York, pp. 317–37.Google Scholar
  3. Craft, M.J. and Schiff, A.A. (1980) Psychiatric disturbance in mentally handicapped patients. Br. J. Psychiatry, 137, 250–5.PubMedCrossRefGoogle Scholar
  4. Crammer, J., Barraclough, B. and Heine, B. (1982) The Use of Drugs in Psychiatry, 2nd edn, Gaskell, Royal College of Psychiatrists, London.Google Scholar
  5. Gadow, K.D. and Poling, A.G. (1988) Pharmacotherapy and Mental Retar-dation, Taylor & Francis, London.Google Scholar
  6. Hogg, J.H. (1989) The Administration of Psychotropic and Anticonvulsant Drugs to People with Profound Retardation and Multiple Impairments: Survey Findings. MENCAP, London.Google Scholar
  7. Kiernan, C.C. (1985) Behaviour modification, in Mental Deficiency: The Changing Outlook 4th edn, Clarke, A.M., Clarke, A.D.B., and Berg, J., Methuen, London.Google Scholar
  8. Kirman, B. (1975) Drug therapy in mental handicap. Br. J. Psychiatry, 127, 545–9.PubMedCrossRefGoogle Scholar
  9. Le Vann, L. (1971) Clinical comparison of haloperidol with chlorpromazine in mentally retarded children. Am. J. Mental Deficiency, 75, 719–23.Google Scholar
  10. Schalock, R.L., Foley, J.W., Toulouse, A. and Stark, J.A. (1985) Medication and programming in controlling the behavior of mentally retarded individuals in community settings. Am. J. Mental Deficiency, 89, 503–9.Google Scholar
  11. Schroeder, S.R. (1985) Drug behaviour interactions with self-injurious behaviour, in The Education and Training of the Mentally Retarded (eds A.F. Ashman and R.S. Laura), Croom Helm, London, pp. 107–43.Google Scholar
  12. Silverstone, T. and Turner, P. (1982) Drug Treatment in Psychiatry, 3rd edn, Routledge & Kegan Paul, London.Google Scholar
  13. Singh, N.N. and Aman, M.G. (1981) Effects of thioridazine dosage on the behavior of severely mentally retarded persons. Am. J. Mental Deficiency, 85, 580–7.Google Scholar
  14. Sprague, R.L. and Baxley, G.B. (1978) Drugs for behavior management, with comment on some legal aspects, in Mental Retardation and Developmental Disabilities, Vol. 10 (ed. J. Wortis ), Brunner/Mazel, New York, pp. 92–129.Google Scholar
  15. Zarkowska, E. and Clements, J. (1988) Problem Behaviour in People with Severe Learning Disabilities. Croom Helm, London.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1987

Authors and Affiliations

  • C. Kiernan

There are no affiliations available

Personalised recommendations